CF
AGN

Copperwynd Financial’s Allergan plc AGN Stock Holding History

Copperwynd Financial’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28,285
Closed -$5.01M – 119
2020
Q1 		$5.01M Buy
28,285
+25,081
+783% +$4.72M 2.37% 7
2019
Q4 		$613K Buy
3,204
+130
+4% +$23.5K 0.32% 61
2019
Q3 		$549K Buy
3,074
+418
+16% +$68.1K 0.31% 67
2019
Q2 		$445K Buy
2,656
+206
+8% +$28.5K 0.26% 66
2019
Q1 		$359K Buy
2,450
+310
+14% +$44.9K 0.22% 87
2018
Q4 		$286K Buy
2,140
+158
+8% +$25.9K 0.18% 80
2018
Q3 		$378K Buy
1,982
+156
+9% +$28.7K 0.23% 74
2018
Q2 		$304K Buy
1,826
+83
+5% +$13.3K 0.21% 76
2018
Q1 		$293K Buy
1,743
+433
+33% +$72.6K 0.2% 77
2017
Q4 		$214K Buy
+1,310
New +$235K 0.16% 88

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Copperwynd Financial's AGN Position: Q2 2020 in Review

Copperwynd Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 28,285 shares — an estimated $5.01M sold.

Copperwynd Financial first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $5.01M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Copperwynd Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Copperwynd Financial sold 28,285 Allergan plc shares in Q2 2020, an estimated $5.01M.
  • Copperwynd Financial first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Copperwynd Financial's Allergan plc position peaked at $5.01M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Copperwynd Financial's 13F filing for Q2 2020, filed 7 Aug 2020.